ArticleAlzheimer's & dementia (New York, N. Y.)

Dementia progression with GLP-1 receptor agonists in people with mild cognitive impairment and type 2 diabetes: target-trial emulation study.

Meir Schechter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.